Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.6572 | 61 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.5318 | 59 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.53641 | 59 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.37775 | 56 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.49696 | 59 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.76481 | 62 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.08624 | 67 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.52524 | 59 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.49269 | 58 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.48959 | 58 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.51965 | 59 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.498 | 59 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.5782 | 59 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.54161 | 59 |